ERYTHRO-STATIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Erythro-statin, and what generic alternatives are available?
Erythro-statin is a drug marketed by Epic Pharma Llc and is included in one NDA.
The generic ingredient in ERYTHRO-STATIN is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Erythro-statin
A generic version of ERYTHRO-STATIN was approved as erythromycin by TORRENT on July 6th, 2020.
Summary for ERYTHRO-STATIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 4,277 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ERYTHRO-STATIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHRO-STATIN
US Patents and Regulatory Information for ERYTHRO-STATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | ERYTHRO-STATIN | erythromycin | SOLUTION;TOPICAL | 064101-001 | Oct 22, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
